Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Rodger David MacArthur, Mark Miller, Timothy Albertson, Edward Panacek, David Johnson, Leah Teoh, William Barchuk

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

As part of the Monoclonal Anti-TNF: A Randomized Controlled Sepsis (MONARCS) trial, which enrolled patients with suspected sepsis, we sought to determine whether adequate antibiotic therapy was associated with a decreased mortality rate. The study enrolled 2634 patients, 91% of whom received adequate antibiotic therapy. The mortality rate among patients given adequate antibiotic treatment was 33%, versus 43% among patients given inadequate treatment (P < .001). We conclude that adequate antibiotic therapy results in a significant decrease in the crude mortality rate among patients suspected of sepsis.

Original languageEnglish (US)
Pages (from-to)284-288
Number of pages5
JournalClinical Infectious Diseases
Volume38
Issue number2
DOIs
StatePublished - Jan 15 2004
Externally publishedYes

Fingerprint

Sepsis
Randomized Controlled Trials
Anti-Bacterial Agents
Survival
Mortality
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis : Experience from the MONARCS Trial. / MacArthur, Rodger David; Miller, Mark; Albertson, Timothy; Panacek, Edward; Johnson, David; Teoh, Leah; Barchuk, William.

In: Clinical Infectious Diseases, Vol. 38, No. 2, 15.01.2004, p. 284-288.

Research output: Contribution to journalArticle

MacArthur, Rodger David ; Miller, Mark ; Albertson, Timothy ; Panacek, Edward ; Johnson, David ; Teoh, Leah ; Barchuk, William. / Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis : Experience from the MONARCS Trial. In: Clinical Infectious Diseases. 2004 ; Vol. 38, No. 2. pp. 284-288.
@article{ac29ab60fbaf47e185804a7ffdb11cf1,
title = "Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial",
abstract = "As part of the Monoclonal Anti-TNF: A Randomized Controlled Sepsis (MONARCS) trial, which enrolled patients with suspected sepsis, we sought to determine whether adequate antibiotic therapy was associated with a decreased mortality rate. The study enrolled 2634 patients, 91{\%} of whom received adequate antibiotic therapy. The mortality rate among patients given adequate antibiotic treatment was 33{\%}, versus 43{\%} among patients given inadequate treatment (P < .001). We conclude that adequate antibiotic therapy results in a significant decrease in the crude mortality rate among patients suspected of sepsis.",
author = "MacArthur, {Rodger David} and Mark Miller and Timothy Albertson and Edward Panacek and David Johnson and Leah Teoh and William Barchuk",
year = "2004",
month = "1",
day = "15",
doi = "10.1086/379825",
language = "English (US)",
volume = "38",
pages = "284--288",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis

T2 - Experience from the MONARCS Trial

AU - MacArthur, Rodger David

AU - Miller, Mark

AU - Albertson, Timothy

AU - Panacek, Edward

AU - Johnson, David

AU - Teoh, Leah

AU - Barchuk, William

PY - 2004/1/15

Y1 - 2004/1/15

N2 - As part of the Monoclonal Anti-TNF: A Randomized Controlled Sepsis (MONARCS) trial, which enrolled patients with suspected sepsis, we sought to determine whether adequate antibiotic therapy was associated with a decreased mortality rate. The study enrolled 2634 patients, 91% of whom received adequate antibiotic therapy. The mortality rate among patients given adequate antibiotic treatment was 33%, versus 43% among patients given inadequate treatment (P < .001). We conclude that adequate antibiotic therapy results in a significant decrease in the crude mortality rate among patients suspected of sepsis.

AB - As part of the Monoclonal Anti-TNF: A Randomized Controlled Sepsis (MONARCS) trial, which enrolled patients with suspected sepsis, we sought to determine whether adequate antibiotic therapy was associated with a decreased mortality rate. The study enrolled 2634 patients, 91% of whom received adequate antibiotic therapy. The mortality rate among patients given adequate antibiotic treatment was 33%, versus 43% among patients given inadequate treatment (P < .001). We conclude that adequate antibiotic therapy results in a significant decrease in the crude mortality rate among patients suspected of sepsis.

UR - http://www.scopus.com/inward/record.url?scp=1642456548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642456548&partnerID=8YFLogxK

U2 - 10.1086/379825

DO - 10.1086/379825

M3 - Article

C2 - 14699463

AN - SCOPUS:1642456548

VL - 38

SP - 284

EP - 288

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -